MyFinsight
Home
Blog
About
Contact
Proceeds from issuances
of common stock...
$74K
Net cash provided by
financing activities
$74K
Net (decrease)
increase in cash and cash...
-$23,255K
Canceled cashflow
$74K
Stock-based compensation
expense
$4,254K
Prepaid expenses and
other current assets
-$1,724K
Non-cash operating lease
expense
$835K
Net amortization
(accretion) on short-term...
-$417K
Other non-current
assets
-$323K
Depreciation expense
$264K
Maturity of short-term
investments
$60,698K
Proceeds from sale of
property, plant and...
$102K
Net cash used in
operating activities
-$19,229K
Net cash (used in)
provided by investing...
-$4,100K
Canceled cashflow
$7,817K
Canceled cashflow
$60,800K
Net loss
-$20,040K
Purchase of short-term
investments
$64,900K
Accrued liabilities
-$6,474K
Operating lease
liabilities
-$320K
Accounts payable
-$118K
Gain on sale of
property plant and...
$94K
Back
Back
Cash Flow
PLIANT THERAPEUTICS, INC. (PLRX)
PLIANT THERAPEUTICS, INC. (PLRX)
source: myfinsight.com